Studying non-mammalian models? Not a fool's ERRand!

Pierre-Luc Bardet1, Vincent Laudet, Jean-Marc Vanacker

  • 1NIMR-Mammalian Development, The Ridgeway, Mill Hill, London NW7 1AA, UK.

Insights

Estrogen-related receptor alpha (ERRalpha) influences estrogen signaling and energy metabolism, making it a potential therapeutic target for diseases like obesity and diabetes. New research also reveals its role in cellular movement, suggesting broader implications for ERR family proteins.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Estrogen-receptor-related receptor (ERR) alpha is an orphan nuclear receptor implicated in estrogen signaling.
  • ERRalpha plays a role in energy storage and consumption, relevant to metabolic disorders.
  • Recent studies explore ERR family functions in non-mammalian models.

Purpose of the Study:

  • To investigate the broader roles of ERRalpha beyond its known functions.
  • To explore the involvement of ERRalpha in cellular processes.
  • To assess the potential of ERRalpha as a pharmaceutical target.

Main Methods:

  • Studies in mammalian model systems.
  • Analysis of ERRalpha in non-mammalian animal models.
  • Investigation of ERR family mechanisms.

Main Results:

  • ERRalpha interferes with estrogen signaling.
  • ERRalpha is involved in energy homeostasis.
  • ERRalpha plays a role in controlling cellular movements.

Conclusions:

  • ERRalpha is a potential therapeutic target for estrogen-related diseases, obesity, and diabetes.
  • The ERR family may be involved in a wider array of cellular processes than previously understood.
  • Further research into ERRalpha and related proteins could uncover novel therapeutic strategies.